| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.02 |